BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24381530)

  • 1. Natural AChE Inhibitors from Plants and their Contribution to Alzheimer's Disease Therapy.
    Murray AP; Faraoni MB; Castro MJ; Alza NP; Cavallaro V
    Curr Neuropharmacol; 2013 Jul; 11(4):388-413. PubMed ID: 24381530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally Occurring Cholinesterase Inhibitors from Plants, Fungi, Algae, and Animals: A Review of the Most Effective Inhibitors Reported in 2012-2022.
    Murray AP; Biscussi B; Cavallaro V; Donozo M; Rodriguez SA
    Curr Neuropharmacol; 2024; 22(10):1621-1649. PubMed ID: 37357520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylcholinesterase inhibitory activity of Ferula plants and their potential for treatment of Alzheimer's disease.
    Bagheri SM; Allahtavakoli M; Moradi A
    J Complement Integr Med; 2023 Mar; ():. PubMed ID: 36857494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients.
    Tuzimski T; Petruczynik A
    Molecules; 2022 May; 27(10):. PubMed ID: 35630702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy.
    Dos Santos TC; Gomes TM; Pinto BAS; Camara AL; Paes AMA
    Front Pharmacol; 2018; 9():1192. PubMed ID: 30405413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease.
    Sivaraman B; Raji V; Velmurugan BA; Natarajan R
    CNS Neurol Disord Drug Targets; 2022; 21(5):427-449. PubMed ID: 34602041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.
    Moss DE; Perez RG
    Curr Alzheimer Res; 2021; 18(13):1010-1022. PubMed ID: 34911424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer's Disease Target.
    Kaufmann D; Kaur Dogra A; Tahrani A; Herrmann F; Wink M
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27589716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs.
    Lazarevic-Pasti T; Leskovac A; Momic T; Petrovic S; Vasic V
    Curr Med Chem; 2017; 24(30):3283-3309. PubMed ID: 28685687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).
    McHardy SF; Wang HL; McCowen SV; Valdez MC
    Expert Opin Ther Pat; 2017 Apr; 27(4):455-476. PubMed ID: 27967267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease.
    Rees TM; Brimijoin S
    Drugs Today (Barc); 2003 Jan; 39(1):75-83. PubMed ID: 12669110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer's disease lead to depression?
    Mitić M; Lazarević-Pašti T
    Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):841-856. PubMed ID: 33999717
    [No Abstract]   [Full Text] [Related]  

  • 13. In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment.
    Innok W; Hiranrat A; Chana N; Rungrotmongkol T; Kongsune P
    J Comput Aided Mol Des; 2021 Mar; 35(3):325-336. PubMed ID: 33439402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning models to select potential inhibitors of acetylcholinesterase activity from SistematX: a natural products database.
    Herrera-Acevedo C; Perdomo-Madrigal C; Herrera-Acevedo K; Coy-Barrera E; Scotti L; Scotti MT
    Mol Divers; 2021 Aug; 25(3):1553-1568. PubMed ID: 34132933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholinesterase inhibitors from plants.
    Mukherjee PK; Kumar V; Mal M; Houghton PJ
    Phytomedicine; 2007 Apr; 14(4):289-300. PubMed ID: 17346955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
    Dey A; Bhattacharya R; Mukherjee A; Pandey DK
    Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706.
    Carvajal FJ; Inestrosa NC
    Front Mol Neurosci; 2011; 4():19. PubMed ID: 21949501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase Inhibitors for Alzheimer's Disease: Multitargeting Strategy Based on Anti-Alzheimer's Drugs Repositioning.
    Kabir MT; Uddin MS; Begum MM; Thangapandiyan S; Rahman MS; Aleya L; Mathew B; Ahmed M; Barreto GE; Ashraf GM
    Curr Pharm Des; 2019; 25(33):3519-3535. PubMed ID: 31593530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the potential of
    Bhattacharya K; Bhattacharjee A; Chakraborty M
    J Biomol Struct Dyn; 2024 Jan; ():1-18. PubMed ID: 38205777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.